Treatment of Alzheimer's disease - New developments

被引：0

作者：

Giacobini, E ^{[1
]}

Michel, JP ^{[1
]}

机构：

[1] Univ Hosp Geneva, Dept Geriatr, Geneva Med Sch, CH-1226 Geneva, Switzerland

来源：

ANNALES DE MEDECINE INTERNE | 1998年 / 149卷 / 04期

关键词：

Alzheimer's disease; Cholinesterase inhibitors;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cholinesterase inhibitors (ChEI) represent the drug of choice for Alzheimer's disease treatment. They produce significant improvement on cognitive as well as non-cognitive function for a period up to one year during the first three years period following clinical onset. The magnitude of cognitive improvements is similar for different ChEI; however, differences are seen with regard to incidence and severity of side effects, incidence of drop-outs, optimal ChE inhibition, pharmacokinetics properties and mode of administration.

引用

页码：231 / 237

页数：7

共 54 条

[1]

ANAND R, 1996, ALZHEIMER DIS MOL BI, P239

[2] ESTROGEN REPLACEMENT THERAPY AND COGNITIVE FUNCTION IN OLDER WOMEN [J].

BARRETTCONNOR, E ;

KRITZSILVERSTEIN, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (20) :2637-2641

[3] Double-blind placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease [J].

Becker, RE ;

Colliver, JA ;

Markwell, SJ ;

Moriearty, PL ;

Unni, LK ;

Vicari, S .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1996, 10 (03) :124-131

[4]

Becker RE, 1996, ALZHEIMER DIS MOL BI, P257

[5]

BECKER RE, 1991, CHOLINERGIC BASIS AL, P263

[6] Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease [J].

Bodick, NC ;

Offen, WW ;

Levey, AI ;

Cutler, NR ;

Gauthier, SG ;

Satlin, A ;

Shannon, HE ;

Tollefson, GD ;

Rasmussen, K ;

Bymaster, FP ;

Hurley, DJ ;

Potter, WZ ;

Paul, SM .

ARCHIVES OF NEUROLOGY, 1997, 54 (04) :465-473

[7] DELAYED-ONSET OF ALZHEIMERS-DISEASE WITH NONSTEROIDAL ANTIINFLAMMATORY AND HISTAMINE-H2 BLOCKING-DRUGS [J].

BREITNER, JCS ;

WELSH, KA ;

HELMS, MJ ;

GASKELL, PC ;

GAU, BA ;

ROSES, AD ;

PERICAKVANCE, MA ;

SAUNDERS, AM .

NEUROBIOLOGY OF AGING, 1995, 16 (04) :523-530

[8] POSTMENOPAUSAL ESTROGEN REPLACEMENT THERAPY AND THE RISK OF ALZHEIMERS-DISEASE - A POPULATION-BASED CASE-CONTROL STUDY [J].

BRENNER, DE ;

KUKULL, WA ;

STERGACHIS, A ;

VANBELLE, G ;

BOWEN, JD ;

MCCORMICK, WC ;

TERI, T ;

LARSON, EB .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (03) :262-267

[9] A CASE-CONTROL STUDY OF ALZHEIMERS-DISEASE IN AUSTRALIA [J].

BROE, GA ;

HENDERSON, AS ;

CREASEY, H ;

MCCUSKER, E ;

KORTEN, AE ;

JORM, AF ;

LONGLEY, W ;

ANTHONY, JC .

NEUROLOGY, 1990, 40 (11) :1698-1707

[10] Protection against Alzheimer's disease? [J].

Burns, A ;

Murphy, D .

LANCET, 1996, 348 (9025) :420-421

← 1 2 3 4 5 6 →